Surgical Management of Breast Amyloidosis.


Journal

Clinical breast cancer
ISSN: 1938-0666
Titre abrégé: Clin Breast Cancer
Pays: United States
ID NLM: 100898731

Informations de publication

Date de publication:
08 2023
Historique:
received: 05 04 2023
accepted: 08 06 2023
medline: 1 8 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

Amyloidosis is characterized by extracellular deposition of insoluble misfolded beta-pleated proteins. Amyloid disease involving the breast is rare and there is a paucity of literature guiding surgical management in caring for these patients. In this article we review medical and surgical management with an emphasis on post mastectomy breast reconstruction. We propose an algorithm for breast reconstructive options based on unique considerations in this patient population. An institutional database at the Medical College of Wisconsin was used to identify patients diagnosed with breast amyloidosis from 2011 to 2021. We utilized the electronic medical record to present patient demographics, diagnostic and treatment data regarding the medical and surgical management of these patients. Five women were identified with a median age of 70 years and a median follow up of 19 months (range, 9-80 months). All patients were diagnosed with light chain (AL) type of amyloidosis. Systemic amyloidosis was identified in 3 patients and localized disease was identified in 2 patients. Concurrent breast malignancy was identified in 2 patients who underwent skin-sparing mastectomies followed by breast reconstruction with both prosthetic and autologous techniques. Both prosthetic and autologous reconstructive techniques are safe in patients with amyloidosis, however careful consideration and preoperative work-up are warranted to avoid complications in this vulnerable population. Further studies are warranted to improve surgical outcomes in patients with amyloidosis involving the breast.

Identifiants

pubmed: 37357131
pii: S1526-8209(23)00153-2
doi: 10.1016/j.clbc.2023.06.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e359-e367

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Anita D’Souza reports institutional research funding from Abbvie, Caelum, Janssen, Novartis, Prothena, Sanofi, Takeda, and TeneoBio, Ad Board fees from BMS, Consulting fees from Prothena and Janssen. The remaining author(s) declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Jonathan T Bacos (JT)

Department of Plastic Surgery, Medical College of Wisconsin, Milwaukee, WI.

Erin Doren (E)

Department of Plastic Surgery, Medical College of Wisconsin, Milwaukee, WI.

Anita D'Souza (A)

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.

Julie Jorns (J)

Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.

Amanda Kong (A)

Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI. Electronic address: akong@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH